T1	Date 25 46	2 de Febrero del 2012
T2	Time 53 58	14:58
T3	LIVB 68 73	varón
T4	Age 77 84	63 años
T5	DISO 89 103	dolor torácico
#1	AnnotatorNotes T5	C0008031; Chest Pain; Sign or Symptom
T6	DISO 153 172	Hipercolesterolemia
#2	AnnotatorNotes T6	C0020443; Hypercholesterolemia; Disease or Syndrome
T7	Neg_cue 174 184	suspendido
T8	PROC 188 191	tto
#3	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	Negated 188 205	tto con estatinas
T10	CHEM 196 205	estatinas
#4	AnnotatorNotes T10	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T11	DISO 222 241	efectos secundarios
#5	AnnotatorNotes T11	C0041755; Adverse reaction to drug; Pathologic Function
T12	DISO 244 247	HTA
#6	AnnotatorNotes T12	C0020538; Hypertensive disease; Disease or Syndrome
T13	PROC 268 271	tto
#7	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	Negated 268 291	tto con betabloqueantes
T15	CHEM 276 291	betabloqueantes
#8	AnnotatorNotes T15	C0001645; Adrenergic beta-Antagonists; Pharmacologic Substance
T16	Neg_cue 303 312	retirados
T17	DISO 317 335	disfunción eréctil
#9	AnnotatorNotes T17	C0242350; Erectile dysfunction; Disease or Syndrome
T18	DISO 338 359	Cardiopatía isquémica
#10	AnnotatorNotes T18	C0151744; Myocardial Ischemia; Disease or Syndrome
T19	Date 364 368	1997
T20	DISO 389 408	ardor retroesternal
#11	AnnotatorNotes T20	C0018834; Heartburn; Sign or Symptom
T21	PROC 423 443	estudio de perfusión
T22	DISO 467 491	isquemia posteroinferior
T23	Neg_cue 511 513	no
T24	Negated 514 536	reversible al esfuerzo
T25	Spec_cue 563 571	probable
T26	DISO 572 580	necrosis
#12	AnnotatorNotes T26	C1334928; Necrotic changes (finding); Finding
T27	Speculated 572 588	necrosis antigua
T28	PROC 591 594	TTO
#13	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	Date 595 601	actual
T30	CHEM 603 612	Diltiazem
#14	AnnotatorNotes T30	C0012373; diltiazem; Organic Chemical · Pharmacologic Substance
T31	Dose 613 619	240 mg
T32	Frequency 619 623	/día
T33	CHEM 625 634	Enalapril
#15	AnnotatorNotes T33	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T34	Dose 635 640	10 mg
T35	Frequency 640 644	/día
T36	DISO 649 659	Enfermedad
#16	AnnotatorNotes T36	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T37	Date 660 666	actual
T38	Date 694 697	hoy
T39	Time 704 709	13:30
T40	PHYS 722 727	comer
#17	AnnotatorNotes T40	C0013470; Eating; Organism Function
T41	DISO 742 770	dolor retroesternal opresivo
T42	ANAT 783 802	zona interescapular
T43	ANAT 807 822	brazo izquierdo
#18	AnnotatorNotes T43	C0230347; Left upper arm structure; Body Part, Organ, or Organ Component
T44	DISO 838 843	mareo
#19	AnnotatorNotes T44	C0012833; Dizziness; Sign or Symptom | C0220870; Lightheadedness; Sign or Symptom
T45	DISO 853 871	cortejo vegetativo
T46	CHEM 898 906	ASPIRINA
#20	AnnotatorNotes T46	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T47	Dose 908 914	500 mg
T48	CHEM 918 921	AAS
#21	AnnotatorNotes T48	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T49	DISO 946 960	dolor torácico
#22	AnnotatorNotes T49	C0008031; Chest Pain; Sign or Symptom
T50	Neg_cue 962 965	sin
T51	DISO 966 972	disnea
#23	AnnotatorNotes T51	C0013404; Dyspnea; Sign or Symptom
T52	Negated 966 972	disnea
T53	PROC 975 981	EXAMEN
#24	AnnotatorNotes T53	C0031809; Physical Examination; Health Care Activity
T54	PROC 984 1003	Exploración general
T55	PROC 1005 1007	TA
T56	PROC 1021 1023	Fc
T57	PROC 1032 1035	SO2
T58	DISO 1041 1049	Afectado
#25	AnnotatorNotes T58	C2945640; compromise; Finding
T59	DISO 1051 1057	pálido
#26	AnnotatorNotes T59	C0030232; Pallor; Finding
T60	PROC 1094 1097	ACP
#27	AnnotatorNotes T60	C0030625; Passive Cutaneous Anaphylaxis; Laboratory Procedure | C0078944; Patient-Controlled Analgesia; Therapeutic or Preventive Procedure
T61	Neg_cue 1122 1124	No
T62	DISO 1125 1127	IY
T63	Negated 1125 1127	IY
T64	Neg_cue 1128 1130	ni
T65	DISO 1131 1145	edemas en EEII
T66	Negated 1131 1145	edemas en EEII
T67	PROC 1148 1171	PRUEBAS COMPLEMENTARIAS
#28	AnnotatorNotes T67	C1515980; Ancillary Study; Research Activity
T68	PROC 1174 1177	ECG
#29	AnnotatorNotes T68	C1623258; Electrocardiography; Diagnostic Procedure
T69	DISO 1183 1188	dolor
#30	AnnotatorNotes T69	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T70	PROC 1202 1210	Rx Tórax
#31	AnnotatorNotes T70	C0039985; Plain chest X-ray; Diagnostic Procedure
T71	Neg_cue 1212 1215	sin
T72	DISO 1216 1228	alteraciones
#32	AnnotatorNotes T72	C0012634; Disease; Disease or Syndrome
T73	Negated 1216 1228	alteraciones
T74	PROC 1242 1251	Analítica
#33	AnnotatorNotes T74	C0002778; Analysis of substances; Laboratory Procedure
T75	PROC 1253 1263	Creatinina
#34	AnnotatorNotes T75	C0201975; Creatinine measurement; Laboratory Procedure
T76	PROC 1269 1276	Glucosa
T77	PROC 1281 1285	Urea
#35	AnnotatorNotes T77	C0523961; Urea measurement; Laboratory Procedure
T78	PROC 1289 1291	Na
#36	AnnotatorNotes T78	C0337443; Sodium measurement; Laboratory Procedure
T79	PROC 1296 1297	K
#37	AnnotatorNotes T79	C0202194; Potassium measurement; Laboratory Procedure
T80	PROC 1303 1328	Troponina T ultrasensible
T81	PROC 1334 1336	CK
#38	AnnotatorNotes T81	C0201973; Creatine kinase measurement; Laboratory Procedure
T82	PROC 1341 1348	ALT-GPT
T83	PROC 1352 1361	Hemograma
#39	AnnotatorNotes T83	C0009555; Complete Blood Count; Laboratory Procedure | C0200631; Complete blood count without differential; Laboratory Procedure | C0852571; Blood counts NEC; Laboratory Procedure
T84	PROC 1369 1372	INR
#40	AnnotatorNotes T84	C0525032; International Normalized Ratio; Laboratory Procedure
T85	PROC 1420 1431	tratamiento
T86	LIVB 1449 1457	paciente
#41	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	Neg_cue 1477 1480	sin
T88	DISO 1481 1486	dolor
#42	AnnotatorNotes T88	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T89	Negated 1481 1486	dolor
T90	Neg_cue 1487 1489	ni
T91	DISO 1490 1496	disnea
#43	AnnotatorNotes T91	C0013404; Dyspnea; Sign or Symptom
T92	Negated 1490 1496	disnea
T93	Time 1507 1512	16:53
T94	PROC 1523 1526	ECG
#44	AnnotatorNotes T94	C1623258; Electrocardiography; Diagnostic Procedure
T95	DISO 1552 1578	Infarto agudo de miocardio
#45	AnnotatorNotes T95	C0027051; Myocardial Infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T96	PROC 1580 1591	TRATAMIENTO
#46	AnnotatorNotes T96	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T97	Dose 1626 1632	2 puff
T98	CHEM 1636 1647	Solinitrina
T99	CHEM 1649 1663	NITROGLICERINA
#47	AnnotatorNotes T99	C0017887; nitroglycerin; Organic Chemical · Pharmacologic Substance
T100	DISO 1677 1682	dolor
#48	AnnotatorNotes T100	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T101	PROC 1684 1687	ECG
#49	AnnotatorNotes T101	C1623258; Electrocardiography; Diagnostic Procedure
T102	Neg_cue 1688 1691	sin
T103	Negated 1692 1699	cambios
T104	Duration 1712 1724	unos minutos
T105	LIVB 1728 1736	paciente
#50	AnnotatorNotes T105	C0030705; Patients; Patient or Disabled Group
T106	DISO 1754 1761	mareado
#51	AnnotatorNotes T106	C0012833; Dizziness; Sign or Symptom | C0027497; Nausea; Sign or Symptom
T107	PROC 1762 1764	TA
T108	PROC 1771 1773	FC
T109	PROC 1782 1787	SatO2
#52	AnnotatorNotes T109	C0523807; Oxygen saturation measurement; Laboratory Procedure
T110	Dose 1798 1804	500 cc
T111	CHEM 1808 1810	SF
T112	PHYS 1820 1822	TA
#53	AnnotatorNotes T112	C0005823; Blood Pressure; Organism Function | C0005903; Body Temperature; Organism Attribute
T113	DISO 1853 1867	sintomatología
#54	AnnotatorNotes T113	C3540840; Sign or Symptom; Finding
T114	CHEM 1870 1881	CLOPIDOGREL
#55	AnnotatorNotes T114	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T115	Dose 1882 1888	300 mg
T116	Route 1890 1898	vía oral
T117	CHEM 1901 1912	ENOXAPARINA
#56	AnnotatorNotes T117	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T118	Dose 1913 1918	30 mg
T119	Route 1919 1922	IV.
T120	CHEM 1926 1937	ENOXAPARINA
#57	AnnotatorNotes T120	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T121	Dose 1938 1943	90 mg
T122	Route 1944 1947	SC.
T123	Time 1955 1960	15:35
T124	CHEM 1970 1978	Metylase
T125	CHEM 1980 1983	TNK
#58	AnnotatorNotes T125	C0872913; tenecteplase; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance
T126	CHEM 1985 1997	TENECTEPLASA
#59	AnnotatorNotes T126	C0872913; tenecteplase; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance
T127	Route 2000 2003	IV.
T128	Dose 1964 1969	10 ml
T129	PROC 1528 1539	DIAGNÓSTICO
T130	Quantifier_or_Qualifier 476 491	posteroinferior
T132	Quantifier_or_Qualifier 514 536	reversible al esfuerzo
T133	Observation 771 822	irradiado a zona interescapular y a brazo izquierdo
T134	Quantifier_or_Qualifier 846 852	ligero
T135	Result_or_Value 1008 1019	121/90 mmHg
T136	Result_or_Value 1024 1030	70 lpm
T137	Result_or_Value 1036 1040	96%.
T138	Observation 1065 1080	bien perfundido
T139	Result_or_Value 1099 1105	normal
T140	CONC 1193 1199	inicio
T141	Quantifier_or_Qualifier 1229 1239	valorables
T142	Result_or_Value 1264 1268	1,66
T143	Result_or_Value 1277 1280	143
T144	Result_or_Value 1286 1288	39
T145	Result_or_Value 1292 1295	138
T146	Result_or_Value 1298 1302	2,82
T147	Result_or_Value 1329 1333	75,5
T148	Result_or_Value 1337 1340	155
T149	Result_or_Value 1349 1351	27
T150	Result_or_Value 1362 1368	normal
T151	Result_or_Value 1373 1377	0,93
T152	Observation 1468 1475	estable
T153	CONC 1692 1699	cambios
T154	Result_or_Value 1765 1770	80/45
T155	Result_or_Value 1774 1780	80 lpm
T156	Result_or_Value 1788 1792	96%.
T157	Observation 1811 1822	recupera TA
T158	Observation 1839 1846	mejoría
T159	Patient 68 73	varón
T162	Patient 1449 1457	paciente
T163	Patient 1728 1736	paciente
T165	Observation 210 215	temor
T166	History_of 153 172	Hipercolesterolemia
T167	History_of 244 247	HTA
T168	History_of 338 359	Cardiopatía isquémica
T169	History_of 389 408	ardor retroesternal
T170	Quantifier_or_Qualifier 492 509	equivalente a 10%
T131	Observation 1083 1092	hidratado
T160	ANAT 1141 1145	EEII
